Noninvasive Monitoring of the Fate of 111In-labeled Block Copolymer Micelles by High Resolution and High Sensitivity MicroSPECT/CT Imaging
Overview
Affiliations
The validation of high sensitivity and high resolution microSPECT/CT imaging for tracking the in vivo pathway and fate of an 111Indium-labeled (111In) amphiphilic diblock copolymer micelle formulation is presented. Heterobifunctional poly(ethylene glycol) was used to initiate cationic ring opening polymerization of epsilon-caprolactone, which was then conjugated to 2-(4-isothiocyanatobenzyl)-diethylenetriaminepentaacetic acid (p-SCN-Bn-DTPA) for chelation with 111In. The micelles were characterized in terms of their physicochemical properties including size, size distribution, zeta-potential, and radiochemical purity. Elimination kinetics and tissue deposition were evaluated in healthy mice following administration of 111In-micelles, 111In-DTPA-b-PCL unimers (i.e., administered under the critical micelle concentration) or 111In-Bn-DTPA. Healthy and MDA-MB-231 tumor-bearing mice were imaged using microSPECT/CT following iv administration of 111In-micelles or 111In-Bn-DTPA. Overall, incorporation of 111In onto the surface of thermodynamically stable micelles results in long plasma residence times for the radionuclide and preferential localization within the spleen (22 +/- 5% i.d/g), liver (13 +/- 3% i.d./g), and tumor (9 +/- 2% i.d./g). MicroSPECT/CT imaging provided noninvasive longitudinal visualization of circulation dynamics and tissue deposition. A strong correlation between image-based region of interest (ROI) analysis and biodistribution data was found, implying that nuclear imaging can be used as a noninvasive tool to accurately quantify tissue distribution. As well, the image-based assessment provided unique insight into the intratumoral distribution of the micelles in vivo.
Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape.
Reilly R, Georgiou C, Brown M, Cai Z EJNMMI Radiopharm Chem. 2024; 9(1):37.
PMID: 38703297 PMC: 11069497. DOI: 10.1186/s41181-024-00266-y.
Santos J, Azevedo R, Prudencio M, Marques F, Le Gal Y, Lorcy D Pharmaceutics. 2023; 15(3).
PMID: 36986890 PMC: 10058554. DOI: 10.3390/pharmaceutics15031030.
Ahmadi M, Emzhik M, Mosayebnia M Drug Deliv Transl Res. 2023; 13(6):1546-1583.
PMID: 36811810 DOI: 10.1007/s13346-023-01291-1.
Advances in Polymeric Colloids for Cancer Treatment.
Ali I, Althakfi S, Suhail M, Locatelli M, Hsieh M, Alsehli M Polymers (Basel). 2022; 14(24).
PMID: 36559812 PMC: 9788371. DOI: 10.3390/polym14245445.
Mehta A, Michler T, Merkel O Adv Healthc Mater. 2021; 10(7):e2001650.
PMID: 33506607 PMC: 7995229. DOI: 10.1002/adhm.202001650.